A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors. The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.
There seem to be a growing number of cases of high amounts of fluid in the lungs following administration of the opioid overdose antidote naloxone, experts said at a recent meeting of the New York Society of Addiction Medicine annual meeting.